Skip to main content
Equibles
COO logo

COO · Cooper Companies, Inc. · Metrics

Track COO — free

Use COO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research COO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$62.19 -0.74 (-1.18%) At close · Nov 12 Play latest call Q3 2026 earnings call transcript
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$11.83B
Shares
190.16M
Volume · Nov 12 1.95M Avg daily vol (3M) 3.48M

COO metrics

113 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$62.19
Market cap
$11.83B

Price action

23 metrics
Price change (1W)
-2.3%
Price change (30D)
+15.3%
Price change (3M)
-18.0%
Price change (6M)
+5.8%
Price change (YTD)
-23.2%
Price change (1Y)
-12.3%
Trailing year
Price change (5Y)
—
52-week high
$84.32
52-week low
$53.27
Change from 52-week high
-25.4%
Change from 52-week low
+18.1%
Annualized volatility
32.7%
Annualized volatility (3M)
42.6%
Implied volatility (30D)
48.3%
IV rank (1Y)
68.5
IV percentile (1Y)
92.7
Beta
0.5
RSI (14D)
58.1
Price vs SMA 50
+7.0%
Price vs SMA 200
-7.7%
Avg volume (3M)
3.49M
Relative volume
0.5
Average dollar volume
$206.97M

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
190.16M

Valuation

12 metrics
P / E (TTM)
21.6
Trailing earnings · reciprocal yield 4.6%
PEG ratio
0.1
EV / revenue
3.4×
reciprocal yield 29.5%
EV / EBITDA
15.5×
reciprocal yield 6.5%
EV / EBIT
26.4×
reciprocal yield 3.8%
P / sales
2.8×
reciprocal yield 35.4%
P / book
1.4
reciprocal yield 69.6%
FCF yield
5.7%
TTM · current market cap
Buyback yield
5.4%
P / FCF
17.6
reciprocal yield 5.7%
P / operating cash flow
11.6
reciprocal yield 8.6%
Earnings yield
4.8%

Historical valuation

8 metrics
P / E historical average (3Y)
46.5×
reciprocal yield 2.1%
P / E historical average (5Y)
42.8×
reciprocal yield 2.3%
EV / revenue historical average (3Y)
4.8×
reciprocal yield 20.8%
EV / revenue historical average (5Y)
5.4×
reciprocal yield 18.6%
EV / EBIT historical average (3Y)
29.9×
reciprocal yield 3.3%
EV / EBIT historical average (5Y)
33.8×
reciprocal yield 3.0%
EV / EBITDA historical average (3Y)
18.3×
reciprocal yield 5.5%
EV / EBITDA historical average (5Y)
18.3×
reciprocal yield 5.5%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
5.4%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
0
Last ex-dividend
2023-07-26

Earnings calendar

2 metrics
Next earnings
2026-12-03
Last earnings
2026-09-09

Profitability

9 metrics
Gross margin
65.9%
Operating margin
12.8%
Trailing 12 months
Net margin
13.5%
Gross profit (TTM)
$2.79B
Operating profit (TTM)
$544.20M
Net income (TTM)
$570.30M
Trailing 12 months
Diluted EPS (TTM)
$2.92
FCF margin
16.0%
Effective tax rate
-23.3%

Per share

11 metrics
Revenue per diluted share (TTM)
$21.64
Gross profit per diluted share (TTM)
$14.27
Operating profit per diluted share (TTM)
$2.78
EBITDA per diluted share (TTM)
$4.74
Net income per diluted share (TTM)
$2.93
Operating cash flow per diluted share (TTM)
$5.28
Free cash flow per diluted share (TTM)
$3.47
Capital expenditures per diluted share (TTM)
$1.81
R&D per diluted share (TTM)
$0.87
Stock compensation per diluted share (TTM)
—
Book value per share
$42.06

Growth

11 metrics
Revenue growth YoY
+0.6%
Year over year
Net income growth YoY
+340.3%
Revenue (TTM)
$4.24B
Trailing 12 months
EPS growth YoY
+357.1%
Shares change YoY
-3.3%
Year over year · fewer shares
Revenue CAGR (3Y)
+7.3%
Revenue CAGR (5Y)
+11.0%
EPS CAGR (3Y)
-1.2%
EPS CAGR (5Y)
+9.2%
FCF CAGR (3Y)
-1.3%
FCF CAGR (5Y)
+19.7%

Quality

14 metrics
Return on equity
6.8%
Return on assets
4.5%
Debt / equity
0.3
Current ratio
1.2
EBITDA (TTM)
$928.20M
Free cash flow (TTM)
$678.00M
Quick ratio
0.7
Interest coverage
6.1
Net debt / EBITDA
2.6
Return on invested capital
—
Trailing 12 months
Net cash
−$2.39B
Latest balance sheet
Cash & equivalents
$154.70M
Total assets
$12.67B
Total debt
$2.54B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$1.03B
Capital expenditures (TTM)
$355.30M
R&D (TTM)
$169.80M
SG&A (TTM)
$1.89B
Stock compensation (TTM)
—
R&D / revenue
4.0%
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
682
13F filer change QoQ
-2
Institutional ownership
110.3%
Conviction holders (share of 13F filers)
1.2%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+2.8%
Holder tenure
14.4
Price vs estimated holder cost
-3.3%

Ownership (registered funds)

1 metrics
Index-fund ownership
21.8%

Short interest

3 metrics
Short interest
5.3%
Latest settlement · 3.4 days to cover
Days to cover
3.4d
Short-squeeze score
61 / 100

Insider activity

2 metrics
Net insider buying (90D)
$1.88M
Insider-sentiment score
90 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 711404 CUSIP 216648501 13F (30d) 443 filings 399 filers Visit website Investor relations